These companies are expected to be the primary beneficiaries of tax relief and potential major exchange uplisting.
As of late April 2026, the cannabis sector is experiencing a significant revival driven by the from Schedule I to Schedule III. This regulatory shift, effective April 22, 2026 , allows state-licensed medical marijuana businesses to deduct standard business expenses for the first time by removing the burden of IRS Section 280E . Top US Multi-State Operators (MSOs) weed stocks to buy now
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling These companies are expected to be the primary